Wall Street's hottest stocks are making a comeback after tariff turmoil, but are these rebounds worth the commitment? Carrie Bradshaw investigates.
Wall Street's hottest stocks are making a comeback after tariff turmoil, but are these rebounds worth the commitment? Carrie Bradshaw investigates.

Trump's Tariffs and a Tidal Wave of Tech?

Darling in New York we know all about comebacks. From bad dates to worse fashion choices reinvention is practically a sport. But lately it's not just my dating life that's been on a rollercoaster. The stock market after a tango with Trump's tariffs has decided to cha cha its way back to the top. The S&P 500 hit an all time high and the Nasdaq? Well it's been leading the charge driven by those seductive tech stocks. Was it a rebound or just a fling? And were we ready to risk it all for love or money?

The Nasdaq's 'Liberation Day' and a Search for Mr. Big… Upside!

Since April 2 the day Trump in a move that reeked of drama declared 'liberation day,' the Nasdaq has surged over 15%. Suddenly everyone was looking for the next big thing the Mr. Big of the stock world. CNBC Pro in a move that felt almost as calculated as Charlotte hunting for her husband screened for Nasdaq members with market caps of at least $5 billion. The criteria? Stocks with at least 65% buy ratings and a price target implying an upside of 15% or more. The rules were so strict it felt like a pre nup! Were these stocks the ones or were they just another flash in the pan?

BridgeBio Pharma: A Tall Tale of Dwarfism and Wall Street Dreams

First up BridgeBio Pharma. Since April 2 it's surged over 30% bringing its year to date gain above 61%. The FDA even granted one of its subsidiaries orphan drug status for a treatment for hypochondroplasia a form of dwarfism. Four out of five analysts have buy ratings on the stock and the price target suggests a jump of over 34%. A miracle cure on Wall Street as well as Main Street. But could I trust it? Was it a true love story or just a good investment with a sad backstory? Was this stock the new Prada bag of the finance world?

AppLovin': Are We Falling for the Hype?

Then there's AppLovin a name that sounds like a dating app which frankly might be more stable. It's rallied over 19% since April and is up over 6% in 2025 after reporting better than expected earnings. About two out of every three analysts have buy ratings and Wall Street sees an average price target implying a soar of over 41%. But after Big I'm always wary of things that seem too good to be true. Was this just a rebound fling or could it be something more? Did I dare to believe in love or at least a really great stock?

The Price of Love (and Stocks)

The truth is in the world of stocks just like in love there are no guarantees. These companies may be the darlings of Wall Street now but tomorrow? Who knows! As Miranda once said “Maybe we can be each other’s soulmates.” Maybe instead of searching for the perfect stock we should focus on building a well rounded portfolio. It's not just about the upside it's about the stability. It's about finding the stocks that support you challenge you and make you a better investor... and maybe just maybe help you afford a new pair of Manolos.

So I Couldn't Help But Wonder...

So I couldn't help but wonder: in the rollercoaster that is the stock market is it better to chase the quick thrill of a soaring stock or invest in a solid dependable portfolio? Is it better to risk it all for a Mr. Big stock or settle for a steady Eddie? And most importantly can a girl ever really have too many shoes or too much equity?


Comments

  • No comments yet. Become a member to post your comments.